{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:56:31Z","timestamp":1790546191354,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017961","name":"Health Commission of Heilongjiang Province","doi-asserted-by":"publisher","award":["No. 20240303010135"],"award-info":[{"award-number":["No. 20240303010135"]}],"id":[{"id":"10.13039\/100017961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["No. PL2025H054"],"award-info":[{"award-number":["No. PL2025H054"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-026-10830-3","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:05:51Z","timestamp":1790539551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nesfatin-1 as a Cardiovascular-Metabolic-Immune Integrator: Insights from Cellular Cross-talk to Precision Medicine"],"prefix":"10.1007","volume":"19","author":[{"given":"Xinru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Z M Fahim","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-1660","authenticated-orcid":false,"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-9549","authenticated-orcid":false,"given":"Tiankai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"10830_CR1","doi-asserted-by":"publisher","first-page":"104766","DOI":"10.1016\/j.phrs.2020.104766","volume":"156","author":"T Angelone","year":"2020","unstructured":"Angelone T, Rocca C, Pasqua T. Nesfatin-1 in cardiovascular orchestration: From bench to bedside. Pharmacol Res. 2020;156:104766.","journal-title":"Pharmacol Res"},{"issue":"5","key":"10830_CR2","doi-asserted-by":"publisher","first-page":"R601","DOI":"10.1152\/ajpregu.00233.2024","volume":"328","author":"TL Steffen","year":"2025","unstructured":"Steffen TL, Stafford JD, Bocke CR, Samson WK, Yosten GLC. The anorexigenic peptide nesfatin-1 dampens the B cell response to receptor-mediated stimulation through inhibition of NF-\u03baB signaling. Am J Physiol Regul Integr Comp Physiol. 2025;328(5):R601\u201310.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10830_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.apcsb.2019.02.001","volume":"116","author":"AK Leung","year":"2019","unstructured":"Leung AK, Ramesh N, Vogel C, Unniappan S. Nucleobindins and encoded peptides: From cell signaling to physiology. Adv Protein Chem Struct Biol. 2019;116:91\u2013133.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"3\u20134","key":"10830_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000338503","volume":"29","author":"Z Li","year":"2012","unstructured":"Li Z, Xu G, Li Y, Zhao J, Mulholland MW, Zhang W. mTOR-dependent modulation of gastric nesfatin-1\/NUCB2. Cell Physiol Biochem. 2012;29(3\u20134):493\u2013500.","journal-title":"Cell Physiol Biochem"},{"key":"10830_CR5","doi-asserted-by":"publisher","first-page":"156046","DOI":"10.1016\/j.metabol.2024.156046","volume":"162","author":"Y He","year":"2025","unstructured":"He Y, Zhang C, Wu S, Li K, Zhang S, Tian M, et al. Central NUCB2\/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus. Metabolism. 2025;162:156046.","journal-title":"Metabolism"},{"key":"10830_CR6","doi-asserted-by":"crossref","unstructured":"Kmiecik AM, Dzi\u0119giel P, Podhorska-Oko\u0142\u00f3w M. Nucleobindin-2\/Nesfatin-1-A New Cancer Related Molecule? Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22158313"},{"key":"10830_CR7","doi-asserted-by":"publisher","first-page":"111401","DOI":"10.1016\/j.mce.2021.111401","volume":"536","author":"A Nasri","year":"2021","unstructured":"Nasri A, Unniappan S. Nucleobindin-derived nesfatin-1 and nesfatin-1-like peptide stimulate pro-opiomelanocortin synthesis in murine AtT-20 corticotrophs through the cAMP\/PKA\/CREB signaling pathway. Mol Cell Endocrinol. 2021;536:111401.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10830_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12967-023-04236-x","volume":"21","author":"S Ning","year":"2023","unstructured":"Ning S, Liu C, Wang K, Cai Y, Ning Z, Li M, et al. NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway. J Transl Med. 2023;21(1):362.","journal-title":"J Transl Med"},{"issue":"1","key":"10830_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s42003-024-06314-2","volume":"7","author":"A Nasri","year":"2024","unstructured":"Nasri A, Kowaluk M, Widenmaier SB, Unniappan S. Nesfatin-1 and nesfatin-1-like peptide attenuate hepatocyte lipid accumulation and nucleobindin-1 disruption modulates lipid metabolic pathways. Commun Biol. 2024;7(1):623.","journal-title":"Commun Biol"},{"issue":"3","key":"10830_CR10","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1038\/nutd.2015.42","volume":"6","author":"H Shimizu","year":"2016","unstructured":"Shimizu H, Tanaka M, Osaki A. Transgenic mice overexpressing nesfatin\/nucleobindin-2 are susceptible to high-fat diet-induced obesity. Nutr Diabetes. 2016;6(3):e201.","journal-title":"Nutr Diabetes"},{"issue":"Pt 3","key":"10830_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119111","volume":"338","author":"J Zheng","year":"2025","unstructured":"Zheng J, Han J, Wang Y, Xu Y, Yu J, Han B, et al. Antidepressant and anxiolytic effects of Wuling Capsule in CSDS mice: alleviating HPA axis hyperactivity via the Nesfatin-1\/NF-\u03baB signaling pathway. J Ethnopharmacol. 2025;338(Pt 3):119111.","journal-title":"J Ethnopharmacol"},{"key":"10830_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.740174","volume":"12","author":"SK Rupp","year":"2021","unstructured":"Rupp SK, W\u00f6lk E, Stengel A. Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor - a systematic review. Front Endocrinol (Lausanne). 2021;12:740174.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10830_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2024.102400","volume":"136","author":"A Pa\u0142asz","year":"2024","unstructured":"Pa\u0142asz A, Lipiec-Borowicz A, Suszka-\u015awitek A, Kistowska J, Hork\u00e1 P, Ka\u015bkosz A, et al. Spexin and nesfatin-1-expressing neurons in the male human claustrum. J Chem Neuroanat. 2024;136:102400.","journal-title":"J Chem Neuroanat"},{"issue":"3","key":"10830_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2024.152156","volume":"126","author":"A Lipiec-Borowicz","year":"2024","unstructured":"Lipiec-Borowicz A, Pa\u0142asz A, Suszka-\u015awitek A, Filipczyk \u0141, Della Vecchia A, Worthington JJ, et al. Neuropeptides in the rat claustrum - an immunohistochemical detection. Acta Histochem. 2024;126(3):152156.","journal-title":"Acta Histochem"},{"key":"10830_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2015.09.006","volume":"417","author":"Y Yin","year":"2015","unstructured":"Yin Y, Li Z, Gao L, Li Y, Zhao J, Zhang W. AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. Mol Cell Endocrinol. 2015;417:20\u20136.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10830_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bjp.0705930","volume":"143","author":"RS Ostrom","year":"2004","unstructured":"Ostrom RS, Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol. 2004;143(2):235\u201345.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10830_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s44318-024-00300-4","volume":"44","author":"S Geng","year":"2025","unstructured":"Geng S, Yang S, Tang X, Xue S, Li K, Liu D, et al. Intestinal NUCB2\/nesfatin-1 regulates hepatic glucose production via the MC4R-cAMP-GLP-1 pathway. Embo j. 2025;44(1):54\u201374.","journal-title":"Embo j"},{"key":"10830_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chemphyslip.2018.08.003","volume":"216","author":"E Bieberich","year":"2018","unstructured":"Bieberich E. Sphingolipids and lipid rafts: Novel concepts and methods of analysis. Chem Phys Lipids. 2018;216:114\u201331.","journal-title":"Chem Phys Lipids"},{"key":"10830_CR19","doi-asserted-by":"publisher","first-page":"1455153","DOI":"10.3389\/fmolb.2024.1455153","volume":"11","author":"YLM Zulueta Diaz","year":"2024","unstructured":"Zulueta Diaz YLM, Arnspang EC. Super-resolution microscopy to study membrane nanodomains and transport mechanisms in the plasma membrane. Front Mol Biosci. 2024;11:1455153.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10830_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/jnc.12066","volume":"124","author":"K Gotoh","year":"2013","unstructured":"Gotoh K, Masaki T, Chiba S, Ando H, Shimasaki T, Mitsutomi K, et al. Nesfatin-1, corticotropin-releasing hormone, thyrotropin-releasing hormone, and neuronal histamine interact in the hypothalamus to regulate feeding behavior. J Neurochem. 2013;124(1):90\u20139.","journal-title":"J Neurochem"},{"issue":"3","key":"10830_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1095\/biolreprod.116.146621","volume":"96","author":"A Hatef","year":"2017","unstructured":"Hatef A, Unniappan S. Gonadotropin-releasing hormone, kisspeptin, and gonadal steroids directly modulate nucleobindin-2\/nesfatin-1 in murine hypothalamic gonadotropin-releasing hormone neurons and gonadotropes. Biol Reprod. 2017;96(3):635\u201351.","journal-title":"Biol Reprod"},{"key":"10830_CR22","doi-asserted-by":"crossref","unstructured":"Gajewska J, Szamotulska K, Klemarczyk W, Che\u0142chowska M, Struci\u0144ska M, Ambroszkiewicz J. Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention. Nutrients. 2023;15(5).","DOI":"10.3390\/nu15051240"},{"key":"10830_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ygcen.2015.08.003","volume":"224","author":"R Mazza","year":"2015","unstructured":"Mazza R, Gattuso A, Filice M, Cantafio P, Cerra MC, Angelone T, et al. Nesfatin-1 as a new positive inotrope in the goldfish (Carassius auratus) heart. Gen Comp Endocrinol. 2015;224:160\u20137.","journal-title":"Gen Comp Endocrinol"},{"issue":"3","key":"10830_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00018-012-1138-7","volume":"70","author":"T Angelone","year":"2013","unstructured":"Angelone T, Filice E, Pasqua T, Amodio N, Galluccio M, Montesanti G, et al. Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia\/reperfusion injury. Cell Mol Life Sci. 2013;70(3):495\u2013509.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10830_CR25","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s11033-021-06289-x","volume":"48","author":"M Sharifi","year":"2021","unstructured":"Sharifi M, Nazarinia D, Ramezani F, Azizi Y, Naderi N, Aboutaleb N. Necroptosis and RhoA\/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia\/reperfusion injury in a rat model. Mol Biol Rep. 2021;48(3):2507\u201318.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10830_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40709-021-00147-4","volume":"28","author":"M Li","year":"2021","unstructured":"Li M, Li K, Ren Y. Nesfatin-1 protects H9c2 cardiomyocytes against cobalt chloride-induced hypoxic injury by modulating the MAPK and Notch1 signaling pathways. J Biol Res (Thessalon). 2021;28(1):21.","journal-title":"J Biol Res (Thessalon)"},{"issue":"1","key":"10830_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/13813455.2020.1802486","volume":"129","author":"M Naseroleslami","year":"2023","unstructured":"Naseroleslami M, Sharifi M, Rakhshan K, Mokhtari B, Aboutaleb N. Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis. Arch Physiol Biochem. 2023;129(1):122\u201330.","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"10830_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1159\/000430120","volume":"36","author":"J Ying","year":"2015","unstructured":"Ying J, Zhang Y, Gong S, Chang Z, Zhou X, Li H, et al. Nesfatin-1 Suppresses Cardiac L-type Ca\u00b2\u207a Channels Through Melanocortin Type 4 Receptor and the Novel Protein Kinase C Theta Isoform Pathway. Cell Physiol Biochem. 2015;36(2):555\u201368.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"10830_CR29","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1111\/jcmm.16481","volume":"25","author":"RY Su","year":"2021","unstructured":"Su RY, Geng XY, Yang Y, Yin HS. Nesfatin-1 inhibits myocardial ischaemia\/reperfusion injury through activating Akt\/ERK pathway-dependent attenuation of endoplasmic reticulum stress. J Cell Mol Med. 2021;25(11):5050\u20139.","journal-title":"J Cell Mol Med"},{"key":"10830_CR30","doi-asserted-by":"publisher","first-page":"102484","DOI":"10.1016\/j.npep.2024.102484","volume":"109","author":"A Pa\u0142asz","year":"2025","unstructured":"Pa\u0142asz A, Ozimirska K, Suszka-\u015awitek A, Bogus K, B\u0142aszczyk I, Sharma V, et al. Neuroanatomical mapping of spexin and nesfatin-1-expressing neurons in the human brainstem. Neuropeptides. 2025;109:102484.","journal-title":"Neuropeptides"},{"key":"10830_CR31","doi-asserted-by":"publisher","first-page":"170719","DOI":"10.1016\/j.peptides.2021.170719","volume":"149","author":"SK Rupp","year":"2022","unstructured":"Rupp SK, Stengel A. Interactions between nesfatin-1 and the autonomic nervous system-An overview. Peptides. 2022;149:170719.","journal-title":"Peptides"},{"issue":"2","key":"10830_CR32","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1152\/ajpregu.00087.2025","volume":"329","author":"CR Bocke","year":"2025","unstructured":"Bocke CR, Yosten GLC, Samson WK. The antidipsogenic action of nesfatin-1 requires activation of a GLP-1 receptor. Am J Physiol Regul Integr Comp Physiol. 2025;329(2):R253\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10830_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fpsyt.2019.00910","volume":"10","author":"Q Ma","year":"2019","unstructured":"Ma Q, Li X, Yan Z, Jiao H, Wang T, Hou Y, et al. Xiaoyaosan Ameliorates Chronic Immobilization Stress-Induced Depression-Like Behaviors and Anorexia in Rats: The Role of the Nesfatin-1-Oxytocin-Proopiomelanocortin Neural Pathway in the Hypothalamus. Front Psychiatry. 2019;10:910.","journal-title":"Front Psychiatry"},{"issue":"3","key":"10830_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/biof.1600","volume":"46","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen X, Qu Y, Song L, Lin Q, Li M, et al. Central nesfatin-1 activates lipid mobilization in adipose tissue and fatty acid oxidation in muscle via the sympathetic nervous system. BioFactors. 2020;46(3):454\u201364.","journal-title":"BioFactors"},{"issue":"2","key":"10830_CR35","doi-asserted-by":"publisher","first-page":"R330","DOI":"10.1152\/ajpregu.90867.2008","volume":"297","author":"GL Yosten","year":"2009","unstructured":"Yosten GL, Samson WK. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol. 2009;297(2):R330-6.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"10830_CR36","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.2337\/db15-0282","volume":"64","author":"M Tanida","year":"2015","unstructured":"Tanida M, Gotoh H, Yamamoto N, Wang M, Kuda Y, Kurata Y, et al. Hypothalamic Nesfatin-1 Stimulates Sympathetic Nerve Activity via Hypothalamic ERK Signaling. Diabetes. 2015;64(11):3725\u201336.","journal-title":"Diabetes"},{"issue":"6","key":"10830_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.12355","volume":"126","author":"GC Brailoiu","year":"2013","unstructured":"Brailoiu GC, Deliu E, Tica AA, Rabinowitz JE, Tilley DG, Benamar K, et al. Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats. J Neurochem. 2013;126(6):739\u201348.","journal-title":"J Neurochem"},{"key":"10830_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/JIR.S273446","volume":"13","author":"Y Xu","year":"2020","unstructured":"Xu Y, Chen F, Antioxidant. Anti-Inflammatory and Anti-Apoptotic Activities of Nesfatin-1: A Review. J Inflamm Res. 2020;13:607\u201317.","journal-title":"J Inflamm Res"},{"key":"10830_CR39","doi-asserted-by":"publisher","first-page":"828571","DOI":"10.3389\/fnins.2022.828571","volume":"16","author":"M Durst","year":"2022","unstructured":"Durst M, K\u00f6ncz\u00f6l K, Ocskay K, S\u00edpos K, V\u00e1rnai P, Szilv\u00e1sy-Szab\u00f3 A, et al. Hypothalamic Nesfatin-1 Resistance May Underlie the Development of Type 2 Diabetes Mellitus in Maternally Undernourished Non-obese Rats. Front Neurosci. 2022;16:828571.","journal-title":"Front Neurosci"},{"key":"10830_CR40","doi-asserted-by":"crossref","unstructured":"Kras K, Muszy\u0144ski S, Tomaszewska E, Arciszewski MB. Minireview: Peripheral Nesfatin-1 in Regulation of the Gut Activity-15 Years since the Discovery. Anim (Basel). 2022;12(1).","DOI":"10.3390\/ani12010101"},{"issue":"3","key":"10830_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12020-019-02081-x","volume":"66","author":"S Sha","year":"2019","unstructured":"Sha S, Liu X, Zhao R, Qing L, He Q, Sun L, et al. Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice. Endocrine. 2019;66(3):494\u2013502.","journal-title":"Endocrine"},{"issue":"4","key":"10830_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cmet.2019.03.002","volume":"29","author":"S Tsai","year":"2019","unstructured":"Tsai S, Winer S, Winer DA. Gut T Cells Feast on GLP-1 to Modulate Cardiometabolic Disease. Cell Metab. 2019;29(4):787\u20139.","journal-title":"Cell Metab"},{"issue":"8","key":"10830_CR43","first-page":"e67232","volume":"16","author":"AD Kaye","year":"2024","unstructured":"Kaye AD, Sala KR, Abbott BM, Dicke AN, Johnson LD, Wilson PA, et al. The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review. Cureus. 2024;16(8):e67232.","journal-title":"Cureus"},{"issue":"16","key":"10830_CR44","doi-asserted-by":"publisher","first-page":"8044","DOI":"10.18632\/aging.204953","volume":"15","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang C, Zhang H, Li L, Fan T, Jin Z. The alleviating effect and mechanism of GLP-1 on ulcerative colitis. Aging. 2023;15(16):8044\u201360.","journal-title":"Aging"},{"key":"10830_CR45","doi-asserted-by":"publisher","first-page":"3094642","DOI":"10.1155\/2016\/3094642","volume":"2016","author":"YS Lee","year":"2016","unstructured":"Lee YS, Jun HS. Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. Mediators Inflamm. 2016;2016:3094642.","journal-title":"Mediators Inflamm"},{"key":"10830_CR46","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G, Montefusco L, Lunati ME, Usuelli V, Pastore I, Lazzaroni E, et al. The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacol Res. 2022;182:106320.","journal-title":"Pharmacol Res"},{"key":"10830_CR47","doi-asserted-by":"publisher","first-page":"1790420","DOI":"10.3389\/fgstr.2026.1790420","volume":"5","author":"JJ Lee","year":"2026","unstructured":"Lee JJ, Bajgain P, Lightner AL. GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity. Front Gastroenterol (Lausanne). 2026;5:1790420.","journal-title":"Front Gastroenterol (Lausanne)"},{"issue":"10","key":"10830_CR48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2174\/1381612823666170130154407","volume":"23","author":"N Ramesh","year":"2017","unstructured":"Ramesh N, Gawli K, Pasupulleti VK, Unniappan S. Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease. Curr Pharm Des. 2017;23(10):1453\u201364.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10830_CR49","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.19102\/icrm.2023.14111","volume":"14","author":"S Rafaqat","year":"2023","unstructured":"Rafaqat S. Adipokines and Their Role in Heart Failure: A Literature Review. J Innov Card Rhythm Manag. 2023;14(11):5657\u201369.","journal-title":"J Innov Card Rhythm Manag"},{"issue":"1","key":"10830_CR50","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JOE-16-0361","volume":"232","author":"R Dore","year":"2017","unstructured":"Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol. 2017;232(1):R45\u201365.","journal-title":"J Endocrinol"},{"issue":"10","key":"10830_CR51","doi-asserted-by":"publisher","first-page":"R722","DOI":"10.1152\/ajpregu.00396.2013","volume":"306","author":"GL Yosten","year":"2014","unstructured":"Yosten GL, Samson WK. Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin. Am J Physiol Regul Integr Comp Physiol. 2014;306(10):R722\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10830_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/hr.2013.122","volume":"37","author":"A Osaki","year":"2014","unstructured":"Osaki A, Shimizu H. Peripheral administration of nesfatin-1 increases blood pressure in mice. Hypertens Res. 2014;37(2):185\u20136.","journal-title":"Hypertens Res"},{"issue":"11","key":"10830_CR53","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1210\/en.2009-0578","volume":"150","author":"A Stengel","year":"2009","unstructured":"Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, M\u00f6nnikes H, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology. 2009;150(11):4911\u20139.","journal-title":"Endocrinology"},{"issue":"1\u20133","key":"10830_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.regpep.2009.06.009","volume":"157","author":"S Noetzel","year":"2009","unstructured":"Noetzel S, Stengel A, Inhoff T, Goebel M, Wisser AS, Bannert N, et al. CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul Pept. 2009;157(1\u20133):84\u201391.","journal-title":"Regul Pept"},{"issue":"2","key":"10830_CR55","doi-asserted-by":"publisher","first-page":"e2609","DOI":"10.1038\/cddis.2017.28","volume":"8","author":"M Yang","year":"2017","unstructured":"Yang M, Wang J, Wu S, Yuan L, Zhao X, Liu C, et al. Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-\u03b4-dependent neurocircuitry. Cell Death Dis. 2017;8(2):e2609.","journal-title":"Cell Death Dis"},{"key":"10830_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.peptides.2013.06.006","volume":"46","author":"H Dai","year":"2013","unstructured":"Dai H, Li X, He T, Wang Y, Wang Z, Wang S, et al. Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction. Peptides. 2013;46:167\u201371.","journal-title":"Peptides"},{"issue":"1","key":"10830_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12933-021-01355-x","volume":"20","author":"NPE Kadoglou","year":"2021","unstructured":"Kadoglou NPE, Korakas E, Lampropoulos S, Maratou E, Kassimis G, Patsourakos N, et al. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study. Cardiovasc Diabetol. 2021;20(1):166.","journal-title":"Cardiovasc Diabetol"},{"key":"10830_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.peptides.2013.07.017","volume":"49","author":"A Szlachcic","year":"2013","unstructured":"Szlachcic A, Sliwowski Z, Krzysiek-Maczka G, Majka J, Surmiak M, Pajdo R, et al. New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors. Peptides. 2013;49:9\u201320.","journal-title":"Peptides"},{"issue":"1160","key":"10830_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/postgradmedj-2020-139227","volume":"98","author":"\u015e Beyaz","year":"2022","unstructured":"Beyaz \u015e, Akbal E. Increased serum nesfatin-1 levels in patients with inflammatory bowel diseases. Postgrad Med J. 2022;98(1160):446\u20139.","journal-title":"Postgrad Med J"},{"issue":"11","key":"10830_CR60","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.peptides.2007.09.005","volume":"28","author":"W Pan","year":"2007","unstructured":"Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides. 2007;28(11):2223\u20138.","journal-title":"Peptides"},{"issue":"2","key":"10830_CR61","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s43032-020-00324-1","volume":"28","author":"T Li","year":"2021","unstructured":"Li T, Wei S, Fan C, Tang D, Luo D. Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8\/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K\/AKT\/mTOR and AKT\/GSK3\u03b2 Pathway. Reprod Sci. 2021;28(2):550\u201361.","journal-title":"Reprod Sci"},{"issue":"6 Pt A","key":"10830_CR62","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.bbadis.2018.04.002","volume":"1864","author":"QB Lu","year":"2018","unstructured":"Lu QB, Wang HP, Tang ZH, Cheng H, Du Q, Wang YB, et al. Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling. Biochim Biophys Acta Mol Basis Dis. 2018;1864(6 Pt A):2154\u201368.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10830_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuro.2019.07.001","volume":"74","author":"S Nazarnezhad","year":"2019","unstructured":"Nazarnezhad S, Rahmati M, Shayannia A, Abbasi Z, Salehi M, Khaksari M. Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis. Neurotoxicology. 2019;74:196\u2013202.","journal-title":"Neurotoxicology"},{"issue":"4","key":"10830_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/07315724.2019.1646678","volume":"39","author":"G \u00d6zt\u00fcrk \u00d6zkan","year":"2020","unstructured":"\u00d6zt\u00fcrk \u00d6zkan G. Effects of Nesfatin-1 on Food Intake and Hyperglycemia. J Am Coll Nutr. 2020;39(4):345\u201351.","journal-title":"J Am Coll Nutr"},{"key":"10830_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neulet.2016.03.018","volume":"619","author":"M Ozcan","year":"2016","unstructured":"Ozcan M, Gok ZB, Kacar E, Serhatlioglu I, Kelestimur H. Nesfatin-1 increases intracellular calcium concentration by protein kinase C activation in cultured rat dorsal root ganglion neurons. Neurosci Lett. 2016;619:177\u201381.","journal-title":"Neurosci Lett"},{"issue":"5","key":"10830_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/10641963.2017.1384487","volume":"40","author":"A Barutcigil","year":"2018","unstructured":"Barutcigil A, Tasatargil A. Effects of nesfatin-1 on atrial contractility and thoracic aorta reactivity in male rats. Clin Exp Hypertens. 2018;40(5):414\u201320.","journal-title":"Clin Exp Hypertens"},{"key":"10830_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/srep40961","volume":"7","author":"XL Shen","year":"2017","unstructured":"Shen XL, Song N, Du XX, Li Y, Xie JX, Jiang H. Nesfatin-1 protects dopaminergic neurons against MPP(+)\/MPTP-induced neurotoxicity through the C-Raf-ERK1\/2-dependent anti-apoptotic pathway. Sci Rep. 2017;7:40961.","journal-title":"Sci Rep"},{"key":"10830_CR69","doi-asserted-by":"publisher","first-page":"115687","DOI":"10.1016\/j.bcp.2023.115687","volume":"215","author":"JW Chang","year":"2023","unstructured":"Chang JW, Lin YY, Tsai CH, Liu SC, He XY, Wu YS, et al. Nesfatin-1 stimulates BMP5 expression and osteoclastogenesis in rheumatoid arthritis. Biochem Pharmacol. 2023;215:115687.","journal-title":"Biochem Pharmacol"},{"key":"10830_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.npep.2018.10.005","volume":"74","author":"D Chen","year":"2019","unstructured":"Chen D, Cao S, Chang B, Ma T, Gao H, Tong Y, et al. Increasing hypothalamic nucleobindin 2 levels and decreasing hypothalamic inflammation in obese male mice via diet and exercise alleviate obesity-associated hypogonadism. Neuropeptides. 2019;74:34\u201343.","journal-title":"Neuropeptides"},{"key":"10830_CR71","doi-asserted-by":"publisher","first-page":"149200","DOI":"10.1016\/j.gene.2024.149200","volume":"940","author":"S Galande","year":"2025","unstructured":"Galande S, Ravikanth VV, Tokala RK, Satyanarayana Singh S, Rao GV, Talukdar R, et al. Transcriptomic analysis of pancreatic tissue from humans and mice identifies potential gene signatures and unexplored pathways during progression from acute to chronic pancreatitis. Gene. 2025;940:149200.","journal-title":"Gene"},{"key":"10830_CR72","doi-asserted-by":"publisher","first-page":"578966","DOI":"10.3389\/fphys.2020.578966","volume":"11","author":"L Recinella","year":"2020","unstructured":"Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S, Adipokines. New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases. Front Physiol. 2020;11:578966.","journal-title":"Front Physiol"},{"issue":"1","key":"10830_CR73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12964-024-01873-7","volume":"22","author":"XX Zhu","year":"2024","unstructured":"Zhu XX, Meng XY, Chen G, Su JB, Fu X, Xu AJ, et al. Nesfatin-1 enhances vascular smooth muscle calcification through facilitating BMP-2 osteogenic signaling. Cell Commun Signal. 2024;22(1):488.","journal-title":"Cell Commun Signal"},{"key":"10830_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2024.171315","volume":"182","author":"J Ha","year":"2024","unstructured":"Ha J, Yang H. Nesfatin-1 expressed in human endometrial stromal cell line (THESC) stimulates decidualization through FAK\/PI3K\/AKT signaling pathway. Peptides. 2024;182:171315.","journal-title":"Peptides"},{"key":"10830_CR75","doi-asserted-by":"crossref","unstructured":"Papp RS, K\u00f6ncz\u00f6l K, S\u00edpos K, T\u00f3th ZE. Nesfatin-1 Neurons in the Ventral Premammillary Nucleus Integrate Metabolic and Reproductive Signals in Male Rats. Int J Mol Sci. 2025;26(2).","DOI":"10.3390\/ijms26020739"},{"issue":"13","key":"10830_CR76","doi-asserted-by":"publisher","first-page":"e32524","DOI":"10.1016\/j.heliyon.2024.e32524","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Huang B, Feng J, Fan S, Hu Z, Ren S, et al. Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K\/AKT\/mTOR signaling pathway to improve diabetic erectile dysfunction. Heliyon. 2024;10(13):e32524.","journal-title":"Heliyon"},{"issue":"9","key":"10830_CR77","first-page":"5071","volume":"24","author":"ZZ Wang","year":"2020","unstructured":"Wang ZZ, Chen SC, Zou XB, Tian LL, Sui SH, Liu NZ. Nesfatin-1 alleviates acute lung injury through reducing inflammation and oxidative stress via the regulation of HMGB1. Eur Rev Med Pharmacol Sci. 2020;24(9):5071\u201381.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10830_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/ijbs.77987","volume":"19","author":"JW Chang","year":"2023","unstructured":"Chang JW, Liu SC, Lin YY, He XY, Wu YS, Su CM, et al. Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy. Int J Biol Sci. 2023;19(1):281\u201393.","journal-title":"Int J Biol Sci"},{"key":"10830_CR79","doi-asserted-by":"crossref","unstructured":"Nazarinejad Z, Alaeddini B, Ghalami J, Asghari-Jafarabadi M, Ebrahimzadeh-Attari V, Roozbeh-Nasiraie L et al. Strain-Specific Effects of three Different Native Lactobacillus on Anthropometric Indices, Appetite, and Nesfatin-1 in Obese Adults: A Triple-Blind Randomized Clinical Trial. Probiotics Antimicrob Proteins. 2026.","DOI":"10.1007\/s12602-026-10961-8"},{"issue":"7","key":"10830_CR80","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/met.2018.0010","volume":"16","author":"K Chen","year":"2018","unstructured":"Chen K, Zhuo T, Wang J, Mei Q. Saxagliptin Upregulates Nesfatin-1 Secretion and Ameliorates Insulin Resistance and Metabolic Profiles in Type 2 Diabetes Mellitus. Metab Syndr Relat Disord. 2018;16(7):336\u201341.","journal-title":"Metab Syndr Relat Disord"},{"key":"10830_CR81","doi-asserted-by":"publisher","first-page":"882686","DOI":"10.3389\/fpubh.2022.882686","volume":"10","author":"K Huang","year":"2022","unstructured":"Huang K, Liang Y, Wang K, Wu J, Luo H, Yi B. Influence of circulating nesfatin-1, GSH and SOD on insulin secretion in the development of T2DM. Front Public Health. 2022;10:882686.","journal-title":"Front Public Health"},{"issue":"4","key":"10830_CR82","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00467-024-06569-1","volume":"40","author":"M Bade\u0144ska","year":"2025","unstructured":"Bade\u0144ska M, Bade\u0144ski A, Janek A, Szczepa\u0144ska M. The role of nesfatin-1 in kidney diseases. Pediatr Nephrol. 2025;40(4):901\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10830_CR83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1590\/0004-282x-anp-2020-0520","volume":"80","author":"M Altas","year":"2022","unstructured":"Altas M, Uca AU, Akdag T, Odabas FO, Tokgoz OS. Serum levels of irisin and nesfatin-1 in multiple sclerosis. Arq Neuropsiquiatr. 2022;80(2):161\u20137.","journal-title":"Arq Neuropsiquiatr"},{"key":"10830_CR84","doi-asserted-by":"crossref","unstructured":"Kati \u015eD, \u00d6zben S, K\u00fc\u00e7\u00fcksayan E, Van M, Cilli EY, Yaman A et al. Nesfatin-1 as a Potential Biomarker for Ischemic Stroke: A Case-Controlled Study of a Comparative Analysis of Patients with and Without Internal Carotid Artery Stenosis. Diagnostics (Basel). 2025;15(6).","DOI":"10.3390\/diagnostics15060664"},{"issue":"8","key":"10830_CR85","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/08039488.2020.1772363","volume":"74","author":"S Karadeniz","year":"2020","unstructured":"Karadeniz S, Yaman H, Bilginer \u00c7, H\u0131zarc\u0131 Bulut S, Yaman S. Serum nesfatin-1, ghrelin, and lipid levels in adolescents with first episode drug na\u00efve unipolar depression. Nord J Psychiatry. 2020;74(8):613\u20139.","journal-title":"Nord J Psychiatry"},{"key":"10830_CR86","doi-asserted-by":"crossref","unstructured":"Cicho\u0144 L, Pa\u0142asz A, Wilczy\u0144ski KM, Suszka-\u015awitek A, \u017bmijowska A, Jelonek I et al. Evaluation of Peripheral Blood Concentrations of Phoenixin, Spexin, Nesfatin-1 and Kisspeptin as Potential Biomarkers of Bipolar Disorder in the Pediatric Population. Biomedicines. 2023;12(1).","DOI":"10.3390\/biomedicines12010084"},{"key":"10830_CR87","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2147\/CIA.S361459","volume":"17","author":"X Wu","year":"2022","unstructured":"Wu X, Dai B, Yan F, Chen Y, Xu Y, Xia Q, et al. Serum Cortisol, Nesfatin-1, and IL-1\u03b2: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression. Clin Interv Aging. 2022;17:567\u201376.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10830_CR88","first-page":"1577","volume":"19","author":"XQ Wang","year":"2020","unstructured":"Wang XQ, Zheng Y, Fang PF, Song XB. Nesfatin-1 is a potential diagnostic biomarker for gastric cancer. Oncol Lett. 2020;19(2):1577\u201383.","journal-title":"Oncol Lett"},{"key":"10830_CR89","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.metop.2020.100034","volume":"6","author":"M Schenk","year":"2020","unstructured":"Schenk M, Reichmann R, Koelman L, Pfeiffer AFH, Rudovich NN, Aleksandrova K. Intra-individual reproducibility of galectin-1, haptoglobin, and nesfatin-1 as promising new biomarkers of immunometabolism. Metabol Open. 2020;6:100034.","journal-title":"Metabol Open"},{"issue":"10","key":"10830_CR90","first-page":"777","volume":"21","author":"S Sobhan Bahreiny","year":"2023","unstructured":"Sobhan Bahreiny S, Ahangarpour A, Asghar Hemmati A, Kazemzadeh R, Bastani MN, Reza Dabbagh M, et al. Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Int J Reprod Biomed. 2023;21(10):777\u201388.","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"10830_CR91","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1038\/s41467-023-43589-1","volume":"14","author":"MA Funk","year":"2023","unstructured":"Funk MA, Leitner J, Gerner MC, Hammerler JM, Salzer B, Lehner M, et al. Interrogating ligand-receptor interactions using highly sensitive cellular biosensors. Nat Commun. 2023;14(1):7804.","journal-title":"Nat Commun"},{"issue":"10","key":"10830_CR92","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1210\/js.2018-00246","volume":"2","author":"MA Schalla","year":"2018","unstructured":"Schalla MA, Stengel A. Current Understanding of the Role of Nesfatin-1. J Endocr Soc. 2018;2(10):1188\u2013206.","journal-title":"J Endocr Soc"},{"issue":"3","key":"10830_CR93","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00018-022-04193-6","volume":"79","author":"X Chen","year":"2022","unstructured":"Chen X, Dong J, Jiao Q, Du X, Bi M, Jiang H. Sibling battle or harmony: crosstalk between nesfatin-1 and ghrelin. Cell Mol Life Sci. 2022;79(3):169.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10830_CR94","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1194\/jlr.TR120000658","volume":"61","author":"D Sviridov","year":"2020","unstructured":"Sviridov D, Mukhamedova N, Miller YI. Lipid rafts as a therapeutic target. J Lipid Res. 2020;61(5):687\u201395.","journal-title":"J Lipid Res"},{"key":"10830_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4939-1752-5_8","volume":"1232","author":"S Mahammad","year":"2015","unstructured":"Mahammad S, Parmryd I. Cholesterol depletion using methyl-\u03b2-cyclodextrin. Methods Mol Biol. 2015;1232:91\u2013102.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10830_CR96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1(1):31\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10830_CR97","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","volume":"18","author":"S Mishra","year":"2021","unstructured":"Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18(6):400\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10830_CR98","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s43587-024-00662-8","volume":"4","author":"J Wen","year":"2024","unstructured":"Wen J, Tian YE, Skampardoni I, Yang Z, Cui Y, Anagnostakis F, et al. The genetic architecture of biological age in nine human organ systems. Nat Aging. 2024;4(9):1290\u2013307.","journal-title":"Nat Aging"},{"key":"10830_CR99","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.2147\/DMSO.S323009","volume":"14","author":"D Xu","year":"2021","unstructured":"Xu D, Yu Y, Xu Y, Ge J. Plasma Nesfatin-1: potential predictor and diagnostic biomarker for cognitive dysfunction in T2DM patient. Diabetes Metab Syndr Obes. 2021;14:3555\u201366.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"10830_CR100","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2013.03.090","volume":"434","author":"U Sedbazar","year":"2013","unstructured":"Sedbazar U, Maejima Y, Nakata M, Mori M, Yada T. Paraventricular NUCB2\/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats. Biochem Biophys Res Commun. 2013;434(3):434\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"10830_CR101","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2015.00179","volume":"6","author":"U Andreasson","year":"2015","unstructured":"Andreasson U, Perret-Liaudet A, van Waalwijk LJ, Blennow K, Chiasserini D, Engelborghs S, et al. A Practical Guide to Immunoassay Method Validation. Front Neurol. 2015;6:179.","journal-title":"Front Neurol"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10830-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-026-10830-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10830-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:02:00Z","timestamp":1790542920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-026-10830-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10830"],"URL":"https:\/\/doi.org\/10.1007\/s12265-026-10830-3","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}